Skip to main content
logo
Cannara Biotech Inc. (TSX:LOVE)
Canada flag Canada · Delayed Price · Currency is CAD
1.770
-0.010 (-0.56%)
Apr 28, 2026, 3:55 PM EST

Cannara Biotech Revenue

Cannara Biotech had revenue of 30.11M CAD in the quarter ending November 30, 2025, with 20.11% growth. This brings the company's revenue in the last twelve months to 112.36M, up 28.06% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth.

Revenue (ttm)
112.36M
Revenue Growth
+28.06%
P/S Ratio
1.55
Revenue / Employee
250.03K
Employees
452
Market Cap
174.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2025107.32M25.17M30.64%
Aug 31, 202482.15M24.59M42.71%
Aug 31, 202357.56M21.57M59.91%
Aug 31, 202236.00M18.73M108.48%
Aug 31, 202117.27M15.17M723.42%
Aug 31, 20192.10M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ascend Wellness Holdings686.36M
Aurora Cannabis373.12M
TerrAscend357.26M
Organigram Global279.99M
Auxly Cannabis Group151.48M
Medexus Pharmaceuticals136.34M
HLS Therapeutics76.10M
Charlotte's Web Holdings68.41M
Revenue Rankings

Cannara Biotech News

More News